Health Care/Hospital
WOORIEN launches 'MyVet CT Plus': Advanced Veterinary imaging Solution
* Lowering CT barriers and improving diagnostic quality * Spiral-Linear Technology with Enhanced Power * Various and Wide FOV with Reduced Scan Time HWASEONG, South Korea, Oct. 25, 2024 /PRNewswire/ -- WOORIEN Co., Ltd, a company specializing in veterinary imaging equipment and solutions, pr...
2024-10-25 21:00
2434
Lifezoom Unveils Next-Gen 3-in-1 Handheld Red Light Therapy Wand - Transform Your Skincare Routine
NEW YORK, Oct. 25, 2024 /PRNewswire/ -- Lifezoom, a new force in red light therapy with strong R&D capabilities, is about to launch its handheld red light therapy wand, its newest device, as a declaration of its high-end brand route and also shows its determination of providing users with safer a...
2024-10-25 21:00
1058
LakeShore Biopharma Granted Phase III Clinical Trial Approval to Explore Simplified Regimens for YSJA Rabies Vaccine
GAITHERSBURG, Md., Oct. 25, 2024 /PRNewswire/ -- LakeShore Biopharma Co., Ltd (Nasdaq: LSB) ("LakeShore Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for i...
2024-10-25 20:30
1817
Prudential launches first-in-market insurtech solutions MedScreen+ with Reinsurance Group of America
HONG KONG, Oct. 25, 2024 /PRNewswire/ -- Prudential Hong Kong Limited ("Prudential") is proud to be the first insurer inHong Kong to launch MedScreen+, an innovative digital underwriting tool developed in collaboration with Reinsurance Group of America, Incorporated ("RGA"), a leading global lif...
2024-10-25 20:12
2118
MicuRx Announces the Successful Completion of Phase 1 Clinical Trial of MRX-5 in Australia
SHANGHAI, Oct. 25, 2024 /PRNewswire/ -- Recently, Shanghai MicuRx Pharmaceutical Co., Ltd. ("MicuRx", 688373.SH) announced the successful completion of Phase I clinical trial of MRX-5 inAustralia, a self-developed oral antibacterial agent in development for the treatment of nontuberculous mycoba...
2024-10-25 19:29
1321
Corvia Medical Announces Three-Year Clinical Trial Results Confirming Significant and Durable Benefits of the Corvia Atrial Shunt in Heart Failure Patients
44% reduction in total heart failure event rate and ongoing improvements in quality of life in responder group patients implanted with shunt TEWKSBURY, Mass., Oct. 25, 2024 /PRNewswire/ -- Corvia Medical, Inc, a company dedicated to transforming the treatment of heart failure, today announced im...
2024-10-25 19:20
1647
Brinc Hosts Its 4th Successful Asia Health Innovation Summit 2024, as Part of StartmeupHK Festival, Curated by InvestHK
HONG KONG, Oct. 25, 2024 /PRNewswire/ -- The Asia Health Innovation Summit 2024
2024-10-25 18:34
1594
Global Times: Chinese insurers pursue innovative programs to shore up elderly care
BEIJING, Oct. 25, 2024 /PRNewswire/ -- Pension finance has been elevated to a strategic priority since the Central Financial Work Conference held in 2023 outlined the industry as one of the five most important areas for the high-quality development of the country's financial sector. In recent ye...
2024-10-25 18:20
1368
Ribbon of Hope: A Collaborative Cancer Support Initiative by BIG Pharmacy and CARiNG Pharmacy
JOHOR BAHRU, Malaysia, Oct. 25, 2024 /PRNewswire/ -- BIG CARiNG Group proudly announces the unveiling of its revolutionary Cancer Support Program, namely "Ribbon of Hope" for you and those you care for at the Biggest Health & Beauty Expo held at Mid Valley Southkey. This initiative is designed to...
2024-10-25 15:25
1601
TASTE-2 World Stroke Congress | Sanbexin ® combined with thrombectomy significantly reduces stroke disability
NANJING, China, Oct. 25, 2024 /PRNewswire/ -- On October 24, 2024, TASTE-2, a Chinese innovative stroke drug study led by Professor Wang Yongjun from Beijing Tiantan Hospital, was published in an oral report at the 16th World Stroke Conference (WSC): brain cell protection combined with edaravone ...
2024-10-25 15:14
1141
HiConf Seoul 2024 successfully wraps up, sparks up discussions for future of food tech and international partnerships
* Global food tech experts gathered to share innovative ideas, discuss market insights, and explore development potential * Abu Dhabi-based investment firm HITI partners with Dongwha Pharmaceutical to manufacture and distribute cognitive enhancement ingredients in theMiddle East * HITI join...
2024-10-25 10:39
2305
Everest Medicines Announces the Launch of VELSIPITY® in the Guangdong-Hong Kong-Macau Greater Bay Area, Offering a New Option for Moderately to Severely Active Ulcerative Colitis Patients
SHANGHAI, Oct. 25, 2024 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing and commercialization of innovative therapeutics, today announced that, through the "Hong Kong and Ma...
2024-10-25 07:40
1632
Volpara Health Surpasses 300 Peer-Reviewed Papers
Milestone reinforces readership in AI-powered breast cancer detection WELLINGTON, New Zealand, Oct. 25, 2024 /PRNewswire/ -- Volpara Health, a Lunit company and global leader in artificial intelligence (AI)-powered breast health solutions, has reached a significant milestone: the publication ...
2024-10-25 00:00
1904
Shaklee, A Leader in Clean Wellness and Skincare, Expands into Australia
The Brand Ushers in a New Era of Growth as It Approaches Its 75th Anniversary MIAMI, Oct. 24, 2024 /PRNewswire/ -- Shaklee, a leading health and wellness company, whose founder invented the first multivitamin in the U.S., is launching in its newest international market:Australia. The news comes a...
2024-10-24 22:03
2903
Frost & Sullivan Honors Industry Leaders with Prestigious 2024 Best Practices Awards
Top Innovators Recognized for Outstanding Achievements at Semiannual Awards Gala SAN ANTONIO, Oct. 24, 2024 /PRNewswire/ -- The 2024 Frost & Sullivan Best Practices Awards Gala, hosted at the JW Marriott Tucson Starr Pass Resort in Tucson, AZ, brought together the best in business to celebrate tra...
2024-10-24 22:00
1242
EpiVax and CUBRC Awarded FDA Contract Worth $2M for Development of Control Peptides for Immunogenicity Risk Assessment Assays Supporting Regulatory Filings of Generic Peptide Drugs
PROVIDENCE, R.I., Oct. 24, 2024 /PRNewswire/ -- EpiVax, Inc. ("EpiVax") and CUBRC, Inc. ("CUBRC") announce today that they have been awarded a two-year,$2 million contract (#75F40124C00094) from the Office of Generic Drugs (OGD) of the Food and Drug Administration (FDA) to develop standardized co...
2024-10-24 21:05
1694
IMG Announces 2024 Leave Your Mark Grant Winners
INDIANAPOLIS, Oct. 24, 2024 /PRNewswire/ -- IMG (International Medical Group), an award-winning global insurance benefits and assistance services company, is excited to announce the winners of its eighth annual Leave Your Mark Grant. This year, more than 800 organizations and individuals submitte...
2024-10-24 21:00
1096
Innovation at the Forefront: Angel Yeast Shines at FHA 2024
SINGAPORE, Oct. 24, 2024 /PRNewswire/ -- The FHA 2024 exhibition in Singapore,
Asia's largest food and beverage show, is taking place from October 22 to 25,
and is generating significant buzz within the hospitality sector. Angel Yeast
2024-10-24 20:30
5311
Besmile Announces RMB 1 Million Donation to Support Shanghai 9th People's Hospital's Dental Service Development
SHANGHAI, Oct. 24, 2024 /PRNewswire/ -- Dental service provider Besmile proudly announces a donation ofRMB 1 million to Shanghai 9th People's Hospital, reinforcing its commitment to enhancing dental service capabilities within the industry. The fund will help elevate the medical facilities to cre...
2024-10-24 20:20
5059
Medera Announces Completion of Cohort A and Initiation of Dosing in Cohort B of MUSIC-HFpEF, a Phase 1/2a Clinical Trial Evaluating First-In-Human Gene Therapy SRD-002 for Heart Failure with Preserved Ejection Fraction
* Heart failure is a global pandemic with an estimated 64.3 million cases worldwide, costing overUS$100B per year * Heart failure with preserved ejection fraction (HFpEF) accounts for nearly half of all heart failure cases, but has limited disease-modifying therapeutics * Promising efficacy ...
2024-10-24 20:00
1145
Week's Top Stories
Most Reposted
Rocket Travel by Agoda Shares Revealing New Report and Showcases Solution to Transform Hotel Distribution
[Picked up by 313 media titles]
2024-11-21 10:30Rockwell Automation and Microsoft Deliver on a Shared Vision to Accelerate Industrial Transformation
[Picked up by 308 media titles]
2024-11-20 13:29Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
[Picked up by 301 media titles]
2024-11-20 16:30
Travel loyalty programs to focus on offering personalized and flexible customer experiences in 2025
[Picked up by 298 media titles]
2024-11-19 10:42Philips and Edith Cowan University Australia Collaborate to Equip the Next Generation of Healthcare Professionals to leverage new technologies
[Picked up by 284 media titles]
2024-11-20 09:00
Most Read
Strategic Forum in Chongqing Drives Expansion of New Western Land-Sea Corridor
2024-11-16 14:15
5187
